Quebec (Finally) Releases $12 Million for Supervised Injection Sites in Montreal

After years of pleading, debating and waiting, the Quebec Ministry of Health officially released the funds to open three supervised injection sites (SIS), as well as one mobile unit in Montreal. Two such sites are already in function in Vancouver, but it will be a first for Quebec.

Quebec will release $12 million over three years to three community centres in Montreal: Spectre de rue, CACTUS and Dopamine. One part of the money will help the centres prepare the locations and fulfill all the requirements to be granted an exemption from the law on drugs by the federal government.

The other part will be used for the launching and running of the sites’ operations. One mobile unit will also be providing services in a few boroughs. No official date is set for the opening of the facilities, but Le Devoir mentioned that it could be as soon as March 2017.

The project is far from new. In fact, six years have already passed since the Director of Public Health started pushing for the opening of SIS in Montreal. In June 2015, Mayor Coderre had announced his plan to go forward with the facilities, with or without Ottawa’s approval.

At the time, the provincial government decided to lend a hand. According to Lucie Charlebois, Quebec’s Minister of Health and Healthy Living, “we are now at the final step” of the process.

She told Radio-Canada that the work on installations and the hiring of medical staff was already on track. “That means we’re advancing quickly.” She commented that she discussed the matter with her federal counterpart, Jane Philpott: “she is very receptive towards it, but we have to fit certain criteria, that is clear.” Charlebois stated that she believes that getting the federal approval will be a formality.

Sandhia Vadlamudy, the director of CACTUS, told FTB by phone that this formality requires a lot of paperwork, but no problematic modifications.

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)